About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Psychometric Properties Mobility Measures MS | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02339688

Psychometric Properties Mobility Measures MS

Current study will investigate the quality (psychometric properties) and clinical utility of several mobility measures, according to disability level. Therefore, several aspects will be inquired: * W...

Lead sponsor: Hasselt University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Hasselt University

Collaborators

Dept Neurological Rehabilitation Reha Zentrum Münster Gröben
National MS Center Melsbroek
Revalidatie & MS Centrum Overpelt
De Mick
Charles University, Czech Republic
Danish MS Hospitals, Haslev and Ry
Masku Neurological Rehabilitation Center
Quellenhof
Fondazione Don Carlo Gnocchi Onlus
Italian Multiple Sclerosis Foundation
Sheba Medical Center
MS-Senteret Hakadal
Haukeland University Hospital
MS Rehabilitation Center Borne Sulinowo
Clinical center Belgrado
Eugenia Epalza Rehabilitation Center, Bilbao, Spain
Cleveland Mellen MS Center
University of Colorado, Denver
Queen's University
Shepherd Center Atlanta
St. Louis University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of MS according to McDonald criteria24,
•Expanded Disability Status Scale25 (EDSS) ≥ 2 and ≤ 6.5 as determined by neurologists or trained clinician
•no relapse within the last month
•no changes in disease modifying treatment and no corticoid-therapy within the last month
•receive at least 10 sessions of physical therapy (in- or outpatient rehabilitation), with a maximum duration of 3 months

Exclusion Criteria

•other medical conditions interfering with mobility (e.g. stroke, pregnancy, fractures, …)
•other neurological impairments with permanent damage (stroke, Parkinson, …)
•MS-like syndromes such as neuromyelitis optica
•not able to understand and execute simple instructions

Related studies

RECRUITINGPhase 3

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy

Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury

NCT07663266 · Multiple Sclerosis, Spinal Cord Injury

RECRUITINGPhase 2

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

NCT06170970 · Multiple Sclerosis, Multiple Sclerosis Fatigue

RECRUITINGPhase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490 · Multiple Sclerosis Spasticity

RECRUITINGPhase 3

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

NCT07299019 · Secondary Progressive Multiple Sclerosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 14, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment254

Start dateOct 2014

Last updatedJun 14, 2016

Condition

Multiple Sclerosis

Locations shown

Hasselt University

Diepenbeek

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 14, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions